Investigating additive properties to enhance pure blue electroluminescence in perovskite light-emitting diodes.
Quasi-2D (q-2D) perovskite materials can construct a distribution of multiple n phases by incorporating spacer organic cation additives and thus have been widely applied in blue perovskite light-emitting diodes (PeLEDs). However, the lack of research on the regulation of low-n-value q-2D phases by different additives has hindered the development of pure-blue PeLEDs. Herein, by investigating a series of organic cation additives, we identified the key factors governing the assembly of n phases: the additive's steric hindrance and amino group flexibility. Additives with high steric hindrance can effectively segment the 3D perovskite lattice, facilitating the formation of low-n phases. However, increased flexibility of the amino groups in additives that coordinate with the perovskite lattice induces the further assembly of low-n phases into high-n phases during crystallization, whereas low flexibility can anchor low-n phase components and inhibit their further assembly. By utilizing additives with different steric hindrance and flexibility, we achieved the regulation of electroluminescence spectra of all-bromide q-2D perovskites from green (517 nm) to deep blue (449 nm). It was confirmed that the p-F-PEABr additive, featuring high steric hindrance and low amino group flexibility, can effectively control the uniform distribution of low-n phases. Thus, the corresponding q-2D PeLEDs achieved high-quality pure blue electroluminescence at 468 nm with an external quantum efficiency (EQE) of 2.72%, and no obvious spectral shift was observed. This work uncovers the mechanism underlying the effect of spacer additives' steric hindrance and amino group flexibility on the precise regulation of q-2D phase distribution, paving the way for the development of pure blue PeLEDs.
No takes yet. Share an insight, caveat, or question.
Shang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: